主页
市场
图表与思路
Algo
新闻
Store
经纪商
下载
经济日历
交易信号
网页端
键入
/
进行搜索:@user,$symbol
查找
登录
创建账户
中文
English
Русский
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
VYGR
#2924
Voyager Therapeutics, Inc. Common Stock
4.100
0
+0.12%
版块:
基础:
利润货币:
日范围
年范围
日变化
+0.12%
每月变动
+4.06%
6个月变化
-11.83%
年变化
-11.83%
前一天收盘价
4.095
0
Open
4.100
0
Bid
Ask
Low
4.100
0
High
4.100
0
交易量
37
市场
股票
医疗保健
VYGR
Open full chart
Financials
Overview
声明
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
37.65 M
38.11 M
43.29 M
54.3 M
55.21 M
—
Valuation ratios
Enterprise value
164.78 M
-14.14 M
161.67 M
419.9 M
241.66 M
697.03 M
Price to earnings ratio
7.3
-1.43
-4.98
3.03
-5.02
-11.22
Price to sales ratio
1.56
2.73
5.64
1.6
4.09
19.93
Price to cash flow ratio
2.76
1.91
18.46
5.15
21.36
-6.31
Price to book ratio
1.73
1.07
3.91
1.7
1.09
1.67
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.14
0.37
0.29
0.38
0.17
0.38
Return on equity %
0.24
0.75
0.79
0.56
0.22
0.49
Return on invested capital %
127.67
443.71
209.91
485.3
263.96
457.92
Gross margin %
100
100
100
100
100
400
Operating margin %
16
196.76
124.27
48.8
104.11
2 074.2
EBITDA margin %
—
—
—
—
—
—
Net margin %
21.47
190.29
113.45
52.93
81.25
1 874.68
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
7.39
2.68
1.72
4.96
5.56
23.27
Inventory turnover
—
—
—
—
—
—
Asset turnover
0.56
0.16
0.23
0.98
0.21
0.09
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
2.59
1.42
0.33
1.75
0.27
2
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
4.85
3.52
3.1
5.18
5.76
19.18
Net current asset value per share
5.3
3.63
3.25
7.17
4.8
16.62
Tangible book value per share
4.13
2.52
1.54
5.3
5.2
17.77
Working capital per share
4.58
2.28
1.35
5.73
3.94
13.75
Book value per share
4.13
2.52
1.54
5.3
5.2
17.77
新闻
Fortrea Holdings Inc. (FTRE) Q4 Earnings and Revenues Lag Estimates
Alzheimer's Clinical Trial Results, Sadly Running True To Form
J&J Halts Alzheimer's Trial After Drug Fails To Slow Clinical Decline - Johnson & Johnson (NYSE:JNJ)
Voyager Therapeutics股票目标价在H.C. Wainwright下调至25美元
Voyager Therapeutics stock price target lowered to $25 at H.C. Wainwright
航海家治疗公司亮相Stifel会议:神经治疗创新
Voyager Therapeutics at Stifel Conference: Neurotherapeutic Innovations
Leerink Partners将Voyager Therapeutics目标价上调至12美元
Voyager Therapeutics stock price target raised to $12 by Leerink Partners
Voyager TherapeuticsQ3每股收益及营收超出预期
Voyager Therapeutics Inc earnings beat by $0.05, revenue topped estimates
Voyager Therapeutics (VYGR) Reports Q3 Loss, Tops Revenue Estimates